32.50.Z - Production of medical devices, instruments, and products, including dental products
20.13.Z - Manufacture of other inorganic basic chemicals
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
73.11.Z - Advertising agency activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,2 | -2,4 | -3,2 | -32 |
EBITDA | -0,9 | -2,1 | -2,9 | -41,8 |
Short time liabilities | 0,1 | 0,2 | 0,3 | 24,7 |
Equity capital | 9,8 | 7,4 | 7,1 | -3 |
Operating profit (EBIT) | -1,2 | -2,4 | -3,3 | -36,3 |
Assets | 12 | 10,3 | 9,9 | -3,6 |
Net profit (loss) | -1,2 | -2,4 | -3,2 | -31,9 |
Cash | 7,9 | 5 | 4,2 | -16 |
Net income from sale | 0,3 | 0,3 | 0,6 | 131,2 |
Liabilities and provisions for liabilities | 2,2 | 2,9 | 2,8 | -5 |
Working assets | 8,1 | 5,4 | 5,1 | -6,2 |
Depreciation | 0,3 | 0,3 | 0,3 | 2,5 |
% | % | % | p.p. | |
Profitability of capital | -12,3 | -32,5 | -44,3 | -11,8 |
Equity capital to total assets | 81,5 | 71,4 | 71,9 | 0,5 |
Gross profit margin | -440,4 | -916,5 | -523,1 | 393,4 |
EBITDA Margin | -329,4 | -786,6 | -482,3 | 304,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 133 | 330 | 178 | -152 |
Current financial liquidity indicator | 3.6688809394836426 | 1.8444018363952637 | 1.8204326629638672 | 0 |
Net dept to EBITDA | 8.782818794250488 | 2.416262626647949 | 1.4314625263214111 | -1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane